家庭扩展性心肌病:一本小说 简短的MED9同型鉴定
Monica Franzese1, Mario Zanfardino1, Andrea Soricelli1,2
1IRCCS SYNLAB SDN, 80143 Naples, Italy.
International journal of molecular sciences
|March 13, 2024
概括
家庭扩张性心肌病 (DCM) 涉及改变的基因表达. 研究人员发现,MED9基因子单元在DCM患者中显著减少,而较短的MED9异型增加,这表明它在心脏病进展中发挥了新的作用.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
背景情况:
- 家庭扩张性心肌病 (DCM) 是心脏移植的主要原因.
- 包括基因激活/沉默在内的转录基因变化与DCM病变产生有关.
- 中介复合体 (MED) 对于调节基因转录至关重要.
研究的目的:
- 调查家族DCM中MED子单元的变化.
- 确定潜在的目标基因和涉及DCM的途径.
- 了解MED9及其异型在心脏功能障碍中的作用.
主要方法:
- 对来自DCM患者和健康受试者 (HS) 的人类心肌样本进行了RNA测序.
- 分析MED亚单元表达水平,包括MED9及其异型 (MED9f,MED9s).
- 用MED9和GATA4.4进行的动机鉴定和蛋白质与蛋白质相互作用网络分析.
主要成果:
- 在家庭DCM中,有13个MED子单位被调高,7个被调低.
- 与HS患者相比,DCM患者的MED9亚单元表达显著减少 (FC = -1.257,p < 0.05).
- 在DCM患者中,一个短的MED9异型 (MED9s) 与全长异型 (MED9f) 相比上调调.
- MED9和GATA4共享了序列动机,并与涉及心脏发育的蛋白质 (FOG2/ZFPM2,FOS,ID2) 在一个网络中联系在一起.
结论:
- 在与家族性DCM相关的心力衰竭 (HF) 中,观察到调解者综合体的显著变化.
- 在家族性DCM中,MED9显著减少,MED9s异型增加,这表明它可能在疾病中起作用.
- 共同的动机和网络相互作用表明,MED9,GATA4和心脏发育途径之间存在功能联系.
更多相关视频
相关概念视频
02:59Animal Mitochondrial Genetics
7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
01:25Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952